Articles Tagged With:
-
Common Safeguards Identified in OIG Responses
The Department of Health and Human Services Office of Inspector General (OIG) has evaluated several proposed arrangements related to COVID-19 and identified safeguards that pose a low risk of fraud and abuse. Through several responses to proposed arrangements, OIG identified safeguards applicable to most situations that will make remuneration safe from enforcement under anti-kickback and civil monetary penalty rules.
-
DOJ, OIG Changing Enforcement Policies for COVID-19 Era
The federal government’s fraud and abuse enforcement priorities are shifting in response to COVID-19. Risk managers should be ready to adapt their compliance programs in response to the changing risks.
-
Needlestick Injuries Increasing, but Not Always Taken Seriously
Needlestick injuries are on the rise after a long period of decline. Healthcare organizations may not be taking the risk of infection as seriously as they once did. A national expert on needlestick injuries is urging risk managers to reassess prevention programs and respond more aggressively when staff and physicians are injured.
-
CUSP Provides Tools and Support for Improving Safety
The Comprehensive Unit-based Safety Program (CUSP) was developed by safety and quality researchers at the Johns Hopkins Armstrong Institute for Patient Safety and Quality and the Agency for Healthcare Research and Quality. CUSP was developed to improve patient safety by providing tools and support for caregivers that can help them identify and address hazards.
-
Patient Safety Improves with CUSP Approach
A health system in Maine is improving patient safety with the Comprehensive Unit-based Safety Program. This approach emphasizes empowering frontline staff.
-
Study: Few Black Adults Taking Proper Medicine for Difficult-to-Treat Hypertension
Black patients may not receive the right medications or proper lifestyle counseling.
-
Sweeping Patient Safety Action Plan Aims for ‘Foundational Change’
More than two dozen stakeholders created a framework to eliminate preventable medical harm.
-
Does BAMI Spell the End for Cell-Based Therapy After Acute Myocardial Infarction?
Investigators tested the mortality benefit of intracoronary bone marrow cells in patients with successfully reperfused acute myocardial infarction. They observed no effect on mortality.
-
Pulmonary Artery Denervation: A Promising Treatment Option for CTEPH
A trial of patients with residual chronic thromboembolic pulmonary hypertension following pulmonary endarterectomy showed pulmonary artery denervation is superior to medical management with riociguat.
-
When Aortic Stenosis Is Almost Severe: What Happens Next?
A study of patients with normal flow, low gradients, normal left ventricular systolic function but with calculated aortic valve areas <1.0 cm2 showed that about half of them progressed to severe aortic stenosis during the 25-month median follow-up period.